AstraZeneca Said Preliminary Data from a Trial It Conducted on Its COVID-19 Shot, ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'AstraZeneca said preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a third booster dose ...'